• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Vendanta Biosciences

Drugs that may shape 2017 and the trends molding new-drug discovery

Steve Walker    January 20, 2017 May 7, 2018    No Comments on Drugs that may shape 2017 and the trends molding new-drug discovery

Here’s a look at the drugs that may shape 2017, compliments of FirstWord Pharma. It’s a list of some of the products I agree are likely to dominate industry news… Read more »

Corporate, Pharmaceuticals    Acadia Pharmaceuticals, AstraZeneca PLC, Billy Dunn, Center for Drug Evaluation and Research, Chantix, Chrono Therapeutics, Clovis Oncology, CTL019, Docetaxel, Dupilumab, Dupixent, Durvalumab, Epidiolex, Eylea, FirstWord Pharma, Forbes, Herceptin, Juno Therapeutics Inc., Keytruda, Kite Pharma, KTE-C19, Luke Timmerman, Lynparza, National Institutes of Health, Niraparib, Novartis AG, Nuplazid, Nusinersen, Ocrelizumab, Ocrevus, Opdivo, Perjeta, Pertuzumab, Praluent, Prescription Drug User Fee Act, Regeneron Pharmaceuticals Inc., Repatha, Roche Holding AG, Rubraca, Sanofi SA, Second Genome, Seres Therapeutics, Spinraza, Synlogic, Tecentriq, Trastuzumab, Vendanta Biosciences, Verubecestat, Zyban

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.
  • More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.
  • Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.
  • Health-sector IPO market cools off this week after torrid start to November.
    • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
    • Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”
    • Little known Czech biotech’s cell therapy greatly increases survival in ovarian cancer. Sotio’s potential breakthrough and another pipeline cancer candidate...
    • It’s time to reclassify schizophrenia as a neurologic disorder.
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress